Flucindole
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
6,8-difluoro-N,N-dimethyl-2,3,4,9-tetrahydro-1H-carbazol-3-amine
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 40594-09-0 |
| ATC code | None |
| PubChem | CID: 38531 |
| UNII | 5CYU0D0S8M  |
| KEGG | D02658 |
| Chemical data | |
| Formula | C14H18N2 |
| Molecular mass | 250.287 g/mol |
|
|
| (verify) |
Flucindole is an antipsychotic with a tricyclic structure, that was never marketed.[1] It is the 6,8-difluoro derivative of cyclindole.[2]
Synthesis[edit]
See also[edit]
References[edit]
- ^ Wood PL, McQuade PS (1984). "Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics". Progress in Neuro-psychopharmacology & Biological Psychiatry 8 (4-6): 773–7. doi:10.1016/0278-5846(84)90057-5. PMID 6152347.
- ^ Edelson J, Benziger DP (1980). "Disposition of a series of tetrahydrocarbazoles". Drug Metabolism Reviews 11 (2): 263–89. doi:10.3109/03602538008994027. PMID 7011760.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
